Cx08005, a protein tyrosine phosphatase 1b inhibitor, attenuated hepatic lipid accumulation and microcirculation dysfunction associated with nonalcoholic fatty liver disease

HIGHLIGHTS

• who: Jiang Li and collaborators from the Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study, Institute of Materia Beijing, China University, Beijing, China have published the research work: CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease, in the Journal: Pharmaceuticals 2023, 106 of /2023/
• what: This study aimed to investigate the effects of on and in both KKAy mice and diet-induced obesity (DIO) mice. was evaluated by triglyceride determination and B-ultrasound analysis in KKAy mice. The authors evaluated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.